Clinical Trials Logo

Filter by:
NCT ID: NCT05154071 Completed - Clinical trials for Extracorporeal Membrane Oxygenation

Impact of the Implementation of a Referral Veno-venous Extracorporeal Membrane Oxygenation Centre on Mortality

ECMO UNIT
Start date: October 1, 2021
Phase:
Study type: Observational

Current evidence suggest that regrouping patient supported by veno-venous ECMO in high-volume centre could improve outcome. A dedicated ECMO unit was implemented in Dijon. The objective of the present study was to evaluate the implementation of this unit. The hypothesis was that patient taken care within this structured care system would have lower mortality. This research comprises a retrospective observational study conducted in Dijon university hospital

NCT ID: NCT05153902 Completed - Clinical trials for Proximal Humeral Fracture

Impact of Regional Anesthesia on Blood Pressure in Humeral Fracture Surgery

ALR_HUMERUS
Start date: December 1, 2021
Phase:
Study type: Observational

This study aims to compare the hemodynamic impact of two anaesthetic strategies : Regional anesthesia versus General anesthesia in proximal humeral fracture surgery.

NCT ID: NCT05153473 Completed - Hip Arthropathy Clinical Trials

Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties

Start date: June 24, 2019
Phase:
Study type: Observational

Total hip arthroplasty is the preferred treatment for hip disease (primary or secondary osteoarthritis, osteonecrosis, for example) and femoral neck fractures. Revision risk factors reported when considering the main surgical approaches. Studied from the Dutch arthroplasty registry found a revision rate in hemiarthroplasty (HA) of 1.6% at 1 year and 2.5% at 5 years postoperatively. For total hip replacement (THA), the rate was 2.4% at 1 and 4.3% at 5 years postoperatively. Analyze shows that the risk factors for hemiarthroplasty were male sex, age under 80 (regardless of gender), posterolateral approach and uncemented fixation. The risk factors for HAT were exactly the same, but they found that smoking also played a role. It should be noted that age as a risk factor for revision is not a risk during the first year after the fracture, but becomes one in the years that follow. In order to maintain compliance with the directive on medical devices (93/42 / EEC [M5]) and the future regulation (EU) (2017/745) relating to medical devices, SERF has set up post-market clinical follow-ups ( PMCF). This PMCF study aims to improve knowledge related to the performance, safety and benefit / risk ratio of the Sagitta EVL-R stem and to monitor patient care strategy through this clinical evaluation. Significant clinical results as well as safety must be confirmed with this patient cohort. It is important to note that this cohort reflects the specific care strategy of the University Hospital of Poitiers. Therefore, the strategy could be different between hospitals and countries.

NCT ID: NCT05152875 Completed - Clinical trials for Bronchopulmonary Dysplasia

Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia

FunDyP
Start date: March 21, 2022
Phase:
Study type: Observational

The aim of this study is to determine if fungal colonization is associated to severe bronchopulmonary dysplasia in premature infants less than 29 weeks of gestation, and to determine if an association exists between fungal colonization and complications of prematurity and death.

NCT ID: NCT05152862 Completed - Clinical trials for Retinopathy of Prematurity

Improve Screening Criteria for Retinopathy of Prematurity in Two French Center

DEREP3
Start date: March 21, 2022
Phase:
Study type: Observational

The aim of the study is to assess whether a delay of the first examination can be safely considered in French population. Secondary objectives are to describe retinopathy of prematurity (ROP) in a population of premature from two French tertiary NICU and to identify co-morbidities associated with the development of severe ROP.

NCT ID: NCT05152056 Completed - Parotid Tumor Clinical Trials

MRI and Fine Needle Aspiration in the Diagnosis of Parotid Tumors

Parotid
Start date: November 15, 2021
Phase:
Study type: Observational

What value is given to MRI diffusion and perfusion sequences in the diagnosis of parotid tumors? Is a fine needle aspiration associated with MRI systematically necessary? The aim of the research is to study the performance of diffusion and perfusion MRI sequences in the diagnosis of parotid tumors on a large series of cases.

NCT ID: NCT05151770 Completed - Type I Diabetes Clinical Trials

Type 1 Diabetic Post Prandial Glycemia Evaluation Using an Algorithm

EGHYA
Start date: December 30, 2021
Phase:
Study type: Observational

The aim of this study is to demonstrate the efficacy of an algorithm to anticipate the post prandial glycemic profile in type I diabetic patient.

NCT ID: NCT05150470 Completed - Clinical trials for Sleep Apnea Syndromes

Evaluation of the Dental Movements Caused by Oral Appliance in Sleep Apnea Syndrome

DPOAM
Start date: November 25, 2021
Phase: N/A
Study type: Interventional

The DO OAM study is a mono-center, interventional, prospective study carried out in CH VALENCE. It will estimate the prevalence of dental movements in patients treated by oral Appliance for Sleep Apnea syndrome. The investigators will used fingerprinting technique by taking multiple photographs of the teeth that allow for the three-dimensional reconstruction of the teeth this study will provide a better understanding of dental movement caused by oral appliance

NCT ID: NCT05149508 Completed - Peritoneal Dialysis Clinical Trials

Intraperitoneal Pressure Measurements in Children

IPM
Start date: September 23, 2021
Phase:
Study type: Observational

Pediatric peritoneal dialysis is prescribed according to the type of dialysis, the volume infused and the dialysis time. The measurement of intraperitoneal pressure (IPP) is an important and easy indicator to perform. A IPP greater than 18 cmH20 has been correlated with pain and dyspnea, a IPP greater than 14 has been correlated with a higher risk of peritonitis and a IPP greater than 13 was correlated with higher mortality and a switch on hemodialysis. These data suggest the importance of routine IPP measurement. Few data are available in the pediatric population.

NCT ID: NCT05149313 Completed - Dermatitis, Atopic Clinical Trials

A Study of Lebrikizumab in Combination With Topical Corticosteroids in Participants Having Atopic Dermatitis (AD) That Are Not Adequately Controlled or Non-eligible for Cyclosporine

Start date: December 23, 2021
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to evaluate the efficacy of lebrikizumab compared with placebo in participants not adequately controlled with cyclosporine or for whom cyclosporine is not medically advisable up to Week 16.